Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection
暂无分享,去创建一个
Y. Ngo | M. Rudler | D. Thabut | H. Sokol | A. Combes | S. van der Werf | P. Cacoub | T. Poynard | V. Peta | O. Deckmyn | C. Housset | R. Le Grand | R. Marlin | S. Akhavan | M. Sakka | S. Marot | Maisonnasse Pauline | Nesrine Braham Ghedira
[1] Q. Pellenc,et al. Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation , 2021, Scientific Reports.
[2] Zhe Zhu,et al. Low serum level of apolipoprotein A1 may predict the severity of COVID‐19: A retrospective study , 2021, Journal of clinical laboratory analysis.
[3] Maximilian T. Strauss,et al. High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion , 2021, EMBO molecular medicine.
[4] Christoph B. Messner,et al. A time-resolved proteomic and prognostic map of COVID-19 , 2021, Cell Systems.
[5] S. Pol,et al. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020 , 2021, Journal of Hepatology.
[6] K. Nikita,et al. Artificial intelligence in clinical care amidst COVID-19 pandemic: A systematic review , 2021, Computational and Structural Biotechnology Journal.
[7] J. O'connell,et al. Baseline cardiometabolic profiles and SARS-CoV-2 infection in the UK Biobank , 2021, PloS one.
[8] G. Cappellano,et al. Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection , 2021, Frontiers in Molecular Biosciences.
[9] M. V. van Breemen,et al. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models , 2021, Research square.
[10] P. Mavingui,et al. Altered high-density lipoprotein composition and functions during severe COVID-19 , 2021, Scientific Reports.
[11] C. Gale,et al. Association of pre-pandemic high-density lipoprotein cholesterol with risk of COVID-19 hospitalisation and death: the UK Biobank cohort study , 2021, medRxiv.
[12] H. Sokol,et al. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota , 2021, Gut microbes.
[13] Yong Zhou,et al. Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19 , 2020, Frontiers in Cardiovascular Medicine.
[14] Yanhong Zhang,et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry , 2020, Nature Metabolism.
[15] O. Meilhac,et al. Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study , 2020, PloS one.
[16] V. Calvez,et al. Performance of serum apolipoprotein-A1 as a sentinel of Covid-19 , 2020, medRxiv.
[17] G. Preston,et al. Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease , 2020, Journal of proteome research.
[18] Simon J. More,et al. Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases , 2020, BMJ Open.
[19] K. Walley,et al. Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[20] B. Nordestgaard,et al. U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies , 2018, European heart journal.
[21] Y. Ngo,et al. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population. , 2012, Journal of hepatology.
[22] J. L. Ding,et al. Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobin. , 2012, American journal of clinical and experimental immunology.
[23] Y. Ngo,et al. Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age , 2011, BMC gastroenterology.
[24] M. Spagnuolo,et al. The Binding of Haptoglobin to Apolipoprotein AI: Influence of Hemoglobin and Concanavalin A , 2003, Biological chemistry.
[25] P. Bedossa,et al. Alpha-2-macroglobulin and hepatic fibrosis , 1994, Digestive Diseases and Sciences.
[26] C. G. Becker,et al. alpha2-Macroglobulin on human vascular endothelium , 1976, The Journal of experimental medicine.
[27] M. D. De Buyzere,et al. Genetic Polymorphisms in the Host and COVID-19 Infection. , 2021, Advances in experimental medicine and biology.
[28] Y. Ngo,et al. Open Access Research Article Prevalence of Liver Fibrosis and Risk Factors in a General Population Using Non-invasive Biomarkers (fibrotest) , 2022 .